Sign inGet started

ARMO

ARMO BioSciences, Inc.CIK 1693664 ☆ Sign in to watchCongress trades
Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
17

AI insights for ARMO PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
AI insights for ARMO
Insider sentiment score with a plain-English explanation, conviction score on every buy, and how the stock performed 30 and 90 days after past insider buys.
Upgrade to Pro · $99/yearAlready Pro? Log in

Daily buy vs sell · 90 days

No data yet.

Insiders

InsiderRoleTradesBoughtSoldLast trade
Xu StellaDirector5$0$02018-06-22
Rizvi NaiyerDirector3$0$02018-06-22
Leveque JosephChief Medical Officer1$0$02018-06-22
KPCB XIV Associates, LLC10% Owner1$0$02018-06-22
OrbiMed Capital GP IV LLC10% Owner2$0$02018-06-22
Cui XiangminDirector5$0$02018-06-22
Legault PierreDirector3$0$02018-06-22
GORDON CARL LDirector, 10% Owner13$0$02018-06-22
VAN VLASSELAER PETERPresident and CEO5$0$02018-06-22
CROSS HERBChief Financial Officer1$0$02018-06-22
SEIDENBERG BETH CDirector, 10% Owner10$0$02018-06-22
GV 2014, L.P.10% Owner2$0$02018-01-30
GV 2016 GP, L.P.10% Owner2$0$02018-01-30
SEQUOIA CAPITAL CHINA VENTURE FUND VI, L.P.10% Owner2$0$02018-01-30
DAG Ventures Management V, LLCOther20$0$02018-01-30
Kleiner Perkins Caufield & Byers XIV, LLC10% Owner7$0$02018-01-30
ORBIMED ADVISORS LLCDirector, 10% Owner9$0$02018-01-30

Trade history

InsiderRoleCodeTradeFiledSharesPriceValueOwned after
GORDON CARL LDirector D To issuer deriv2018-06-222018-06-2218,000$10.03 $180.5K0SEC↗
SEIDENBERG BETH CDirector D To issuer deriv2018-06-222018-06-2218,000$10.03 $180.5K0SEC↗
Cui XiangminDirector D To issuer deriv2018-06-222018-06-2218,000$10.03 $180.5K0SEC↗
CROSS HERBChief Financial Officer D To issuer deriv2018-06-222018-06-22240,658$43.03 $10.36M0SEC↗
Rizvi NaiyerDirector D To issuer deriv2018-06-222018-06-2218,000$10.03 $180.5K0SEC↗
Rizvi NaiyerDirector D To issuer deriv2018-06-222018-06-2219,146$43.27 $828.4K0SEC↗
Legault PierreDirector D To issuer deriv2018-06-222018-06-2255,765$43.27 $2.41M0SEC↗
Legault PierreDirector D To issuer deriv2018-06-222018-06-2218,000$10.03 $180.5K0SEC↗
VAN VLASSELAER PETERPresident and CEO D To issuer deriv2018-06-222018-06-22190,641$48.68 $9.28M0SEC↗
VAN VLASSELAER PETERPresident and CEO D To issuer deriv2018-06-222018-06-22398,206$46.70 $18.60M0SEC↗
VAN VLASSELAER PETERPresident and CEO D To issuer deriv2018-06-222018-06-22216,168$43.03 $9.30M0SEC↗
VAN VLASSELAER PETERPresident and CEO D To issuer deriv2018-06-222018-06-22220,513$48.68 $10.73M0SEC↗
Leveque JosephChief Medical Officer D To issuer deriv2018-06-222018-06-22288,789$43.03 $12.43M0SEC↗
Xu StellaDirector D To issuer deriv2018-06-222018-06-2218,000$10.03 $180.5K0SEC↗
GORDON CARL LDirector U Tender2018-06-222018-06-22409,547$50.00 $20.48M0SEC↗
GORDON CARL LDirector U Tender2018-06-222018-06-223,709,356$50.00 $185.47M0SEC↗
SEIDENBERG BETH CDirector U Tender2018-06-222018-06-224,266,683$50.00 $213.33M0SEC↗
Cui XiangminDirector U Tender2018-06-222018-06-221,214,700$50.00 $60.73M0SEC↗
KPCB XIV Associates, LLC10% Owner U Tender2018-06-222018-06-224,266,683$50.00 $213.33M0SEC↗
OrbiMed Capital GP IV LLC10% Owner U Tender2018-06-222018-06-223,709,356$50.00 $185.47M3,709,356SEC↗
OrbiMed Capital GP IV LLC10% Owner U Tender2018-06-222018-06-22409,547$50.00 $20.48M409,547SEC↗
VAN VLASSELAER PETERPresident and CEO U Tender2018-06-222018-06-22809,865$50.00 $40.49M0SEC↗
Xu StellaDirector U Tender2018-06-222018-06-22404,900$50.00 $20.25M0SEC↗
Cui XiangminDirector A Award deriv2018-03-262018-03-2818,000— $018,000SEC↗
SEIDENBERG BETH CDirector, 10% Owner A Award deriv2018-03-262018-03-2818,000— $018,000SEC↗
Rizvi NaiyerDirector A Award deriv2018-03-262018-03-2818,000— $018,000SEC↗
Legault PierreDirector A Award deriv2018-03-262018-03-2818,000— $018,000SEC↗
GORDON CARL LDirector, 10% Owner A Award deriv2018-03-262018-03-2818,000— $018,000SEC↗
Xu StellaDirector A Award deriv2018-03-262018-03-2818,000— $018,000SEC↗
GV 2016 GP, L.P.10% Owner C Conversion deriv2018-01-302018-01-30607,350— $00SEC↗
Kleiner Perkins Caufield & Bye10% Owner C Conversion deriv2018-01-302018-01-30403,097— $00SEC↗
Kleiner Perkins Caufield & Bye10% Owner C Conversion deriv2018-01-302018-01-30673,173— $00SEC↗
Kleiner Perkins Caufield & Bye10% Owner C Conversion deriv2018-01-302018-01-301,212,494— $00SEC↗
Kleiner Perkins Caufield & Bye10% Owner C Conversion deriv2018-01-302018-01-301,296,248— $00SEC↗
Kleiner Perkins Caufield & Bye10% Owner C Conversion deriv2018-01-302018-01-30355,429— $00SEC↗
Kleiner Perkins Caufield & Bye10% Owner C Conversion deriv2018-01-302018-01-30326,242— $00SEC↗
Cui XiangminDirector C Conversion deriv2018-01-302018-01-301,214,700— $00SEC↗
GV 2014, L.P.10% Owner C Conversion deriv2018-01-302018-01-30607,350— $00SEC↗
Xu StellaDirector C Conversion deriv2018-01-302018-01-30404,900— $00SEC↗
SEIDENBERG BETH CDirector, 10% Owner C Conversion deriv2018-01-302018-01-30326,242— $00SEC↗
SEIDENBERG BETH CDirector, 10% Owner C Conversion deriv2018-01-302018-01-30403,097— $00SEC↗
SEIDENBERG BETH CDirector, 10% Owner C Conversion deriv2018-01-302018-01-30673,173— $00SEC↗
SEIDENBERG BETH CDirector, 10% Owner C Conversion deriv2018-01-302018-01-301,212,494— $00SEC↗
SEIDENBERG BETH CDirector, 10% Owner C Conversion deriv2018-01-302018-01-301,296,248— $00SEC↗
SEIDENBERG BETH CDirector, 10% Owner C Conversion deriv2018-01-302018-01-30355,429— $00SEC↗
GORDON CARL LDirector, 10% Owner C Conversion deriv2018-01-302018-01-30283,627— $00SEC↗
GORDON CARL LDirector, 10% Owner C Conversion deriv2018-01-302018-01-30415,869— $00SEC↗
GORDON CARL LDirector, 10% Owner C Conversion deriv2018-01-302018-01-301,226,156— $00SEC↗
GORDON CARL LDirector, 10% Owner C Conversion deriv2018-01-302018-01-301,783,704— $00SEC↗
GORDON CARL LDirector, 10% Owner C Conversion deriv2018-01-302018-01-3031,315— $00SEC↗
GORDON CARL LDirector, 10% Owner C Conversion deriv2018-01-302018-01-3045,961— $00SEC↗
GORDON CARL LDirector, 10% Owner C Conversion deriv2018-01-302018-01-30332,271— $00SEC↗
ORBIMED ADVISORS LLCDirector, 10% Owner C Conversion deriv2018-01-302018-01-301,783,704— $00SEC↗
ORBIMED ADVISORS LLCDirector, 10% Owner C Conversion deriv2018-01-302018-01-301,226,156— $00SEC↗
ORBIMED ADVISORS LLCDirector, 10% Owner C Conversion deriv2018-01-302018-01-30415,869— $00SEC↗
ORBIMED ADVISORS LLCDirector, 10% Owner C Conversion deriv2018-01-302018-01-30283,627— $00SEC↗
ORBIMED ADVISORS LLCDirector, 10% Owner C Conversion deriv2018-01-302018-01-30332,271— $00SEC↗
ORBIMED ADVISORS LLCDirector, 10% Owner C Conversion deriv2018-01-302018-01-3045,961— $00SEC↗
ORBIMED ADVISORS LLCDirector, 10% Owner C Conversion deriv2018-01-302018-01-3031,315— $00SEC↗
DAG Ventures Management V, LLCOther C Conversion deriv2018-01-302018-01-30200,786— $00SEC↗
DAG Ventures Management V, LLCOther C Conversion deriv2018-01-302018-01-301,772— $00SEC↗
DAG Ventures Management V, LLCOther C Conversion deriv2018-01-302018-01-30728,080— $00SEC↗
DAG Ventures Management V, LLCOther C Conversion deriv2018-01-302018-01-302,580— $00SEC↗
DAG Ventures Management V, LLCOther C Conversion deriv2018-01-302018-01-301,059,148— $00SEC↗
DAG Ventures Management V, LLCOther C Conversion deriv2018-01-302018-01-30446— $00SEC↗
DAG Ventures Management V, LLCOther C Conversion deriv2018-01-302018-01-30183,351— $00SEC↗
DAG Ventures Management V, LLCOther C Conversion deriv2018-01-302018-01-30226,543— $00SEC↗
DAG Ventures Management V, LLCOther C Conversion deriv2018-01-302018-01-30551— $00SEC↗
DAG Ventures Management V, LLCOther C Conversion deriv2018-01-302018-01-30489— $00SEC↗
SEQUOIA CAPITAL CHINA VENTURE 10% Owner C Conversion deriv2018-01-302018-02-01809,800— $00SEC↗
GV 2016 GP, L.P.10% Owner C Conversion2018-01-302018-01-30607,350— $0607,350SEC↗
Kleiner Perkins Caufield & Bye10% Owner C Conversion2018-01-302018-01-304,266,683— $04,266,683SEC↗
Cui XiangminDirector C Conversion2018-01-302018-01-301,214,700— $01,214,700SEC↗
GV 2014, L.P.10% Owner C Conversion2018-01-302018-01-30607,350— $0607,350SEC↗
Xu StellaDirector C Conversion2018-01-302018-01-30404,900— $0404,900SEC↗
SEIDENBERG BETH CDirector, 10% Owner C Conversion2018-01-302018-01-304,266,683— $04,266,683SEC↗
GORDON CARL LDirector, 10% Owner C Conversion2018-01-302018-01-303,709,356— $03,709,356SEC↗
GORDON CARL LDirector, 10% Owner C Conversion2018-01-302018-01-30409,547— $0409,547SEC↗
ORBIMED ADVISORS LLCDirector, 10% Owner C Conversion2018-01-302018-01-30409,547— $0409,547SEC↗
ORBIMED ADVISORS LLCDirector, 10% Owner C Conversion2018-01-302018-01-303,709,356— $03,709,356SEC↗
DAG Ventures Management V, LLCOther C Conversion2018-01-302018-01-301,059,148— $01,059,148SEC↗
DAG Ventures Management V, LLCOther C Conversion2018-01-302018-01-302,580— $02,580SEC↗
DAG Ventures Management V, LLCOther C Conversion2018-01-302018-01-30728,080— $01,787,228SEC↗
DAG Ventures Management V, LLCOther C Conversion2018-01-302018-01-30446— $05,838SEC↗
DAG Ventures Management V, LLCOther C Conversion2018-01-302018-01-30183,351— $02,397,908SEC↗
DAG Ventures Management V, LLCOther C Conversion2018-01-302018-01-30551— $05,392SEC↗
DAG Ventures Management V, LLCOther C Conversion2018-01-302018-01-30226,543— $02,214,557SEC↗
DAG Ventures Management V, LLCOther C Conversion2018-01-302018-01-30489— $04,841SEC↗
DAG Ventures Management V, LLCOther C Conversion2018-01-302018-01-30200,786— $01,988,014SEC↗
DAG Ventures Management V, LLCOther C Conversion2018-01-302018-01-301,772— $04,352SEC↗
SEQUOIA CAPITAL CHINA VENTURE 10% Owner C Conversion2018-01-302018-02-01809,800— $0809,800SEC↗